BBS9 antibody (AA 37-793) (Cy3)
Quick Overview for BBS9 antibody (AA 37-793) (Cy3) (ABIN7972101)
Target
See all BBS9 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 37-793
-
Purpose
- Anti-BBS9 Antibody Cy3 Conjugated
-
Cross-Reactivity (Details)
- No cross-reactivity with other proteins.
-
Purification
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human BBS9 recombinant protein (Position: Q37-L793).
-
Isotype
- IgG
-
-
-
-
Application Notes
- Flow Cytometry, 1-3 μg/1x106 cells
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Expiry Date
- 12 months
-
-
- BBS9 (Bardet-Biedl Syndrome 9 (BBS9))
-
Alternative Name
- BBS9
-
Background
-
Background: Bardet-Biedl syndrome 9 is a protein that in humans is encoded by the BBS9 gene. This gene is downregulated by parathyroid hormone in osteoblastic cells, and therefore is thought to be involved in parathyroid hormone action in bones. The exact function of this gene has not yet been determined. Alternatively spliced transcript variants encoding different isoforms have been identified.
Gene Full Name: Bardet-Biedl syndrome 9
-
Gene ID
- 27241
-
UniProt
- Q3SYG4
-
Pathways
- Hedgehog Signaling
Target
-